Stay updated on Pembrolizumab in Poor-Prognosis CUP Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 on the page, indicating a subsequent software update to the ClinicalTrials.gov entry.
    Difference
    0.1%
    Check dated 2026-08-11T22:55:20.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The additions expand and clarify the study's secondary and primary endpoints, including RECIST 1.1-based response definitions, duration of response, disease control, and the time frames for OS and PFS. They also specify the assessment of adverse events and the overall analytic time horizons used in the study.
    Difference
    2%
    Check dated 2026-07-21T23:05:44.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Results posted and completion details updated, with enrollment recorded as 33. A PDF of the Study Protocol and Statistical Analysis Plan has been added under Study Documents.
    Difference
    3%
    Check dated 2026-07-07T14:53:17.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.6.0 to v3.6.3, indicating a backend update rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-06-30T10:53:00.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page gained new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention label formatting was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment'. Additionally, a 'No longer looking for participants' note was added and the revision version updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-16T00:24:23.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, indicating a minor backend/frontend update; no study data or enrollment details are changed.
    Difference
    0.1%
    Check dated 2026-06-09T00:51:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Poor-Prognosis CUP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.